R

Ranbaxy Laboratories Ltd (Merged)

RANBAXY NSE
This stock has been delisted or merged and is no longer actively traded.

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Ranbaxy Laboratories Ltd (Merged) insights

29 extracted metrics + investor summaries across FY05–FY14.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

1
  • Debtor days have improved from 74.3 to 57.0 days.

Weaknesses

3
  • Stock is trading at 9.99 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 9.16% over last 3 years.

Growth Rate

Revenue Growth
0.00% →
Net Income Growth
-157.00% →
Cash Flow Change
-
ROE
-18.00% ↘
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Results

  Dec 2011Mar 2012Jun 2012Sep 2012Dec 2012Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014
Sales
3,826
3,781
3,259
2,708
2,711
2,472
2,634
2,802
2,894
2,467
2,416
3,260
2,619
Expenses
3,028
2,690
2,998
2,372
2,658
2,317
2,511
2,602
2,624
2,413
2,286
2,555
2,506
Operating Profit
798
1,091
261
336
53
155
123
199
270
54
130
705
113
OPM %
21%
29%
8%
12%
1.9%
6%
4.7%
7%
9%
2.2%
5%
22%
4.3%
Other Income
-3,443
405
-530
459
-289
144
-451
-346
-119
89
-181
-5
-5
Interest
91
19
165
-16
136
53
159
111
121
114
142
137
147
Depreciation
168
80
78
0
80
80
0
133
92
0
0
0
97
PBT
-2,903
1,398
-512
811
-453
167
-487
-391
-60
30
-192
563
-135
Tax %
3%
10%
13%
7%
8%
21%
6%
15%
163%
371%
-3%
15%
656%
Net Profit
-2,980
1,248
-584
757
-489
130
-523
-453
-162
-79
-189
477
-1,024
EPS in Rs
-70.68
29.54
-13.88
17.86
-11.64
2.97
-12.39
-10.73
-3.75
-1.74
-4.39
11.27
-24.23
Figures in ₹ Crores

Profit & Loss

  Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014 15mTTM
Sales
5,134
6,057
6,684
7,296
7,515
8,876
10,315
12,452
13,259
10,762
Expenses
5,022
5,276
6,143
8,756
6,924
7,806
8,861
10,647
12,281
9,760
Operating Profit
112
781
540
-1,460
591
1,070
1,455
1,805
977
1,002
OPM %
2.2%
13%
8%
-20%
8%
12%
14%
14%
7%
9%
Other Income
259
123
771
448
758
1,463
-3,441
64
-686
-100
Interest
67
104
141
206
71
61
306
304
557
540
Depreciation
109
149
172
282
268
372
394
320
476
97
PBT
194
651
999
-1,500
1,010
2,100
-2,686
1,245
-742
265
Tax %
-36%
21%
21%
-38%
69%
28%
7%
24%
45%
—
Net Profit
264
515
787
-943
307
1,509
-2,890
932
-1,087
-815
EPS in Rs
—
13.69
20.76
-22.63
7.05
35.55
-68.71
21.82
-25.61
-19.09
Div. Payout %
121%
62%
41%
0%
0%
6%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

  Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014
Equity Capital
186
186
187
210
210
211
211
211
212
Reserves
2,261
2,400
2,617
4,086
4,133
5,394
2,658
3,873
3,091
Borrowings
2,004
3,956
4,142
4,285
3,630
4,335
4,491
4,901
6,598
Other Liabilities
1,517
1,891
2,333
4,656
4,165
4,205
8,352
7,466
4,077
Total Liabilities
5,969
8,432
9,278
13,237
12,137
14,144
15,712
16,452
13,978
Fixed Assets
2,059
3,895
4,205
4,490
4,490
4,548
4,830
5,008
5,081
CWIP
560
358
357
471
623
382
227
208
303
Investments
17
36
240
543
541
498
98
79
72
Other Assets
3,333
4,143
4,476
7,733
6,483
8,716
10,557
11,157
8,522
Total Assets
5,969
8,432
9,278
13,237
12,137
14,144
15,712
16,452
13,978
Figures in ₹ Crores

Cash Flow

  Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014
Operating
204
529
1,023
-152
-162
1,539
639
1,582
-3,562
Investing
-838
-1,993
-841
-1,776
54
-2,196
1,781
-1,871
1,958
Financing
746
1,513
-39
2,676
-522
791
-1,218
237
1,016
Net Cash Flow
112
49
143
749
-631
134
1,202
-52
-588
Free Cash Flow
-704
109
587
-586
-653
1,112
190
1,117
-4,335
CFO/OP
213
59
215
1
14
202
59
105
-323
Figures in ₹ Crores

Ratios

  Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014
Debtor Days
81
95
82
67
89
66
106
60
57
Inventory Days
224
248
220
234
219
266
286
246
209
Days Payable
127
130
116
133
171
230
156
146
111
Cash Conversion Cycle
178
213
186
168
137
102
236
159
154
Working Capital Days
113
124
104
-24
32
53
1
-18
56
ROCE %
—
14%
16%
-18%
12%
21%
15%
21%
7%

Documents

Frequently Asked Questions about Ranbaxy Laboratories Ltd (Merged)

What does Ranbaxy Laboratories Ltd (Merged) do?
Ranbaxy Laboratories Limited,Incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in Pharmaceutical
Where is Ranbaxy Laboratories Ltd (Merged) (RANBAXY) listed?
Ranbaxy Laboratories Ltd (Merged) is listed on the Indian stock exchanges. It is listed on NSE: RANBAXY. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Ranbaxy Laboratories Ltd (Merged) belong to?
Ranbaxy Laboratories Ltd (Merged) operates in the Healthcare sector within the Pharmaceuticals & Biotechnology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
How can I research Ranbaxy Laboratories Ltd (Merged) on Tapetide?
On Tapetide, you can view Ranbaxy Laboratories Ltd (Merged)'s live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Ranbaxy Laboratories Limited,Incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in Pharmaceutical

Website ranbaxy.com
Face Value ₹ 5

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List